Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes
Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)
03/2005
03/17/2005US20050059686 Pyrrolopyrimidines as phosphodiesterase vII inhibitors
03/17/2005US20050059633 Novel glucans and novel glucansucrases derived from lactic acid bacteria
03/17/2005US20050059630 TTK in diagnosis and as a therapeutic target in cancer
03/17/2005US20050059622 Methods and compositions for modulating telomerase reverse transcriptase (TERT) expression
03/17/2005US20050059621 preventing apoptosis in neurons that occurs in the presence of beta -amyloid protein, during or after hypoxia or when the neuron exhibits an elevated intracellular calcium concentrations, comprising administering tyrosine kinase inhibitors; treating neurodegenerative diseases
03/17/2005US20050059620 Promoter driven tissue specific cytotoxic agents and title methods of use
03/17/2005US20050059618 Men protein, gst2, rab-rp1, csp, f-box protein lilina/fbl7, abc50, coronin, sec61 alpha, or vhappa1-1, or homologous proteins involved in the regulation of energy homeostasis
03/17/2005US20050059606 hexapeptides including enantiomers, stereoisomers and tautomers, used as enzyme inhibitors for prophylaxis or prevention of viral diseases
03/17/2005US20050059605 arylalkyls coupled to glucagon like peptides, growth hormone releasing hormone, vasoactive intestinal peptides, glucose-dependent Insulinotropic peptides, glucagon, neuropeptide Y, peptide YY or gastrin releasing peptides, used for prevention of metabolic disorders
03/17/2005US20050059603 Compounds which prevent neuronal cell death and uses thereof
03/17/2005US20050059133 Hydrolase comprising reduced immunogenicity for use as diagnostic and therapeutic tool in cancer treatment; immunotherapy; tissue targeted therapy
03/17/2005US20050059132 Variant blood coagulation factor for use as tool in treatment of thrombosis
03/17/2005US20050059131 Detergent compositions containing amylase variants
03/17/2005US20050059130 Lipolytic enzyme variants
03/17/2005US20050059128 Heme domain modified cytochrome p450 monooxygenase for use in hydroxylating linear alkanes using atmospheric dioxygen as an oxidant
03/17/2005US20050059127 Method for recovering proteins from the interstitial fluid of plant tissues
03/17/2005US20050059126 Engineered enzymes comprised of protein scaffold and specificity determining regions; fusion proteins, nucleic acid molecules, vectors, host cells
03/17/2005US20050059118 Hyaluronan receptor for endocytosis
03/17/2005US20050059116 Compositions and methods for inhibiting G2 cell cycle arrest and sensitizing cells to DNA damaging agents
03/17/2005US20050059115 Using biglycan protein to diagnose, prevent and treatment of cell proliferative disorders
03/17/2005US20050059112 Proteases from gram-positive organisms
03/17/2005US20050059111 Pichia methanolica secretory signal
03/17/2005US20050059109 Methods and compositions for polypeptide engineering
03/17/2005US20050059098 Using g-protein coupled receptor specific protein kinases as tool in identifying modulator for treatment of cardiac disorders
03/17/2005US20050059088 Alternatively spliced isoforms of receptor-interacting serine-threonine kinase 2 (RIPK2)
03/17/2005US20050059085 Thermus transcriptional replicative protein for use in identifying modulator which inhibit bacterial growth; rational drug design and screening; bactericides
03/17/2005US20050059081 Dipeptidyl peptidase IV (DPPIV); homology with family of prolyl oligopeptidases; drug screening for enzyme inhibitors for DPPIV which could treat reproductive, inflammatory and metabolic disorders; antibodies for therapeutic or diagnostic use; host cells
03/17/2005US20050059076 Isolated human metalloprotease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof
03/17/2005US20050059075 Peptides for use in diagnosis, prevention and treatment of cell prolifereative, oral and cardiovascular disorders
03/17/2005US20050059073 Expression vector comprising nucleotide sequences coding cell growth factors for use in treatment and prevention of nervous system disorders
03/17/2005US20050059061 Beta, beta-carotene 15,15'-enzymes, nucleic acid sequences coding therefor and their use
03/17/2005US20050059056 Antigenic gp100 (154-162) compounds for therapy and diagnosis and methods for using same
03/17/2005US20050059052 Ire1p, novel mammalian protein, and gene encoding same
03/17/2005US20050059045 Labraries of optimized cytochrome P450 enzymes and the optimized P450 enzymes
03/17/2005US20050059038 Screening mixture and identifying modulators for treatment and prevention of cell proliferative, nervous system, inflammatory and eating disorders
03/17/2005US20050059025 Compositions, organisms and methodologies employing a novel human kinase
03/17/2005US20050059015 A nucleotide sequence and a complement used to screen, diagnose and monitor individuals for obesity and/or diabetes by detecting the presence, absence, or quantity of a translation product of a transcript having a sequence selected from the group of amino acid sequences; antidiabetic agents
03/17/2005US20050059002 Novel serine protease
03/17/2005US20050058998 Amino acid and nucleic acid sequences of cyclic nucleotide phosphodiesterases that are involved in T cell activation and may be used in the diagnosis and treatment of disorders such as autoimmune diseases
03/17/2005US20050058996 Binding phenol oxidizing enzyme-peptide complexes
03/17/2005US20050058995 Primers for use in detecting beta-lactamases
03/17/2005US20050058989 Grapevine leafroll virus proteins and their uses
03/17/2005US20050058747 For use in animal feed, in particular fish feed, and detergents
03/17/2005US20050058650 Administering polypeptides to prevent cell proliferation for cancer treatment with hydrolytic enzymes
03/17/2005US20050058647 Newly identified polypeptide and polynucleotides for diagnosis of new compounds
03/17/2005US20050058627 TTK in diagnosis and as a therapeutic target in cancer
03/17/2005US20050055780 Redeposition or backstain inhibition during stonewashing process
03/17/2005DE10337451A1 Verwendung von PIT-Emulsionen in enzymatischen Reaktionen Use of PIT emulsions in enzymatic reactions
03/17/2005DE102004022065A1 Screeningverfahren für Hydantoinrazemasen Screening process for hydantoin racemases
03/17/2005CA2538012A1 Cyclic nucleotide-specific phosphodiesterases from leishmania and uses thereof
03/17/2005CA2537844A1 Treatment of neurodegenerative diseases
03/17/2005CA2537701A1 One-step reduction and alkylation of proteins
03/17/2005CA2536793A1 Novel ubp8rp polypeptides and their use in the treatment of psoriasis
03/17/2005CA2536782A1 Recombinant production of antimicrobial agents
03/17/2005CA2536650A1 Transformed plants with improved growth characteristics due to increased expression of b-type cdk and methods for making same
03/17/2005CA2525972A1 Methods for identifying inhibitors
03/16/2005EP1515142A1 Mass spectrometry methods for direct phenotyping of factor XIIIA polymorphisms
03/16/2005EP1514942A1 Method of searching substane having antidiabetic activity
03/16/2005EP1514940A1 Chondroitin synthetase and dna coding for the enzyme
03/16/2005EP1514939A1 Chondroitin synthetase and nucleic acid coding for the enzyme
03/16/2005EP1514938A1 Heat-resistant DNA ligase
03/16/2005EP1514937A1 Production of vaccines
03/16/2005EP1514936A2 A novel method to isolate mutants and to clone the complementing gene
03/16/2005EP1514931A1 Immunosuppressant target proteins
03/16/2005EP1514927A1 Novel polyphosphate:amp phosphotransferase
03/16/2005EP1514924A1 Novel acylase gene
03/16/2005EP1514923A1 Enzyme for decomposition of sulfated fucan derived from sea cucumber
03/16/2005EP1514558A1 Use of MARKK or MARKK antagonists for the treatment of pathologies characterised by increased or reduced phosphorylation of MARK or tau protein
03/16/2005EP1514556A1 Botulinum toxin pharmaceutical compositions
03/16/2005EP1513955A2 Diagnostic and therapeutic use of cyp11a1 for neurodegenerative diseases
03/16/2005EP1513946A1 POLYPEPTIDES HAVING a- H-a-AMINO ACID AMIDE RACEMASE ACTIVITY AND NUCLEIC ACIDS ENCODING THE SAME
03/16/2005EP1513943A2 Nicking endonucleases
03/16/2005EP1513940A2 Methods and materials for the production of lactic acid in yeast
03/16/2005EP1513939A2 Fermentation process using specific oxygen uptake rates as a process control
03/16/2005EP1513931A2 Modified phytases
03/16/2005EP1513929A2 Hybrid vector having a cytomegalovirus enhancer and myeloproliferative sarcoma virus promoter
03/16/2005EP1513923A2 Methods and materials for the production of d-lactic acid in yeast
03/16/2005EP1513860A2 P450 enzymes, nucleic acids encoding them and methods of making and using them
03/16/2005EP1513859A2 Kinase suppressor of ras inactivation for therapy of ras mediated tumorigenesis
03/16/2005EP1513553A1 Methods and materials for treating inflammatory conditions
03/16/2005EP1513549A2 Human prolactin antagonist-angiogenesis inhibitor fusion proteins
03/16/2005EP1513542A2 Anti-cancer and wound healing compounds
03/16/2005EP1513394A1 Barley with altered branching enzyme activity and starch and starch containing products with an increased amylose content
03/16/2005EP1513392A1 A method for increasing resistance of monocot plants against abiotic stresses
03/16/2005EP1414939A4 Seed-preferred regulatory elements and uses thereof
03/16/2005EP1343880A4 Expression of xenogenous (human) immunoglobulins in cloned, transgenic ungulates
03/16/2005EP1282688B1 Ammonia-oxidizing bacteria
03/16/2005EP1220899A4 Monoterpene synthases from grand fir (abies grandis)
03/16/2005EP1171143B9 Peptide extract of lupine and pharmaceutical or cosmetic or nutritional composition comprising same
03/16/2005EP1124945B1 Matrix granule
03/16/2005EP1117296B1 Combination of bisphosphonate and tetracycline
03/16/2005EP1032257A4 MONOTERPENE SYNTHASES FROM GRAND FIR ($i(ABIES GRANDIS))
03/16/2005EP1017788A4 MONOTERPENE SYNTHASES FROM COMMON SAGE ($i(SALVIA OFFICINALIS))
03/16/2005EP0948609B1 Llg polypeptides of the triacylglycerol lipase family, and compositions and methods for their use in enzymatic hydrolysis, and protein and gene therapies
03/16/2005EP0910631B1 Enzyme-containing granules and process for the production thereof
03/16/2005EP0869966B1 Prodrugs of thrombin inhibitors
03/16/2005EP0792352B1 Enhanced carotenoid accumulation in storage organs of genetically engineered plants
03/16/2005EP0763127B1 Deblocking the common pathway of aromatic amino acid synthesis
03/16/2005EP0716604B1 Thiol-derivatized nucleosides and oligonucleosides
03/16/2005CN2685344Y Apparatus for in vitro activating human thrombase
1 ... 649 650 651 652 653 654 655 656 657 658 659 660 661 662 663 664 665 666 667 668 669 ... 1416